beta

NVUS

Novus Therapeutics Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap: 21 Million

Primary Exchange: NASDAQ CAPITAL MARKET

Website: http://novustherapeutics.com/

Shares Outstanding: 1.44 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.5378632744776484

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 1717 trading days

From: 2014-09-17 To: 2021-01-04

Lowest Point:

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-12 08:39:07:000

Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-12 08:39:07:000

Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...

Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media

via: Business Wire at 2019-06-10 04:30:00:000

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that data from OP0201 study C-002 will be presented during the 20th International Symposium on Recent Adv… read more...

Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media

via: Business Wire at 2019-06-10 04:30:00:000

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that data from OP0201 study C-002 will be presented during the 20th International Symposium on Recent Adv… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-05-11 9.0 1.0 9.0
Data provided by IEX Cloud